Ngeunaan Dokter
Dr. Jin-hong Park mangrupikeun salah sahiji ahli onkologi radiasi anu paling luhur di Seoul, Koréa Kidul.
- Dr Jin-hong Park atikan
-
- Dokter Kedokteran: Universitas Ulsan
- Master Kedokteran: Universitas Ulsan
- Sarjana Kedokteran: Universitas Nasional Chonbuk
- Dr Jin-hong Park pangalaman profésional
-
- Ngabantosan Profesor dina Onkologi Radiasi, UUCM AMC
- Ukhuwah dina Onkologi Radiasi, UUCM AMC
- Dokter Kaséhatan Umum
- Karésidénan di Radiasi Onkologi, UUCM AMC
- Magang di UUCM AMC
rumah sakit
Pusat Médis Asan, Seoul, Koréa Kidul
Spésialisasi
- Péso Siber,
- Kanker Rektal & Gastrointestinal,
- Radioterapi paliatif,
- uteuk tumor
- Kanker kerongkongan
Prosedur Dilaksanakeun
- Perlakuan péso cyber
- Radioterapi kanker rectal
- Tumor otak radiotherapy
- Radioterapi kanker esophageal
Panilitian & Publikasi
| Evaluasi dosis anu dikirimkeun ka target anu pindah ku rekonstruksi dosis 4D dina terapi busur modulasi volumetrik gated. |
| Terapi radiasi awak stereotaktik ngagunakeun téknik terapi busur volumetrik-gated-gated pikeun karsinoma hépatoselular leutik. |
| Efficacy and safety of neoadjuvant FOLFIRINOX for borderline resectable pancreatic adénokarsinoma: improved efficacy compared with gemcitabine-based regimen |
| Éféktivitas sareng kasalametan implantasi anu dipandu ultrasound tina spidol fiducial dina ati pikeun terapi radiasi awak stereotactic. |
| Impact of a Multidisciplinary Team Approach for Managing Advanced and Recurrent Kangker Colorectal. |
| Local Control Outcomes Using Stereotactic Body Radiation Therapy for Liver Metastases From Colorectal Cancer. |
| Postoperative Radiotherapy for Kangker Pancreatic with Microscopically-positive Resection Margin. |
| Prognosis Pasién Kanker Pankréas sareng Keganasan Sinkron atanapi Metachronous ti Organ Lain Langkung Saé tibatan Anu Kanker Pankréas Ngan. |
| Faktor prognostik di penderita kanker saluran bilier canggih diolah ku gemcitabine lini kahiji tambah cisplatin: analisis retrospective 740 penderita. |
| Pemurnian stratifikasi prognostik karsinoma sél skuamosa oropharyngeal patali papillomavirus manusa: prognosis béda antara T1 sareng T2. |
| Peran radioterapi fractionated di penderita hemangioma tina sinus cavernous. |
| Total Excision Mesorectal Versus Excision Lokal Saatos Tanggapan nguntungkeun pikeun Chemoradiotherapy Preoperative di "Awal" Klinis T3 Rectal Kangker: A Propensity Score Analisis. |
| Gated Volumetric-dimodulasi Arc Terapi vs Tumor-nyukcruk CyberKnife Radiotherapy sakumaha Stereotactic Awak Radiotherapy pikeun Carcinoma Hepatocellular: Hiji studi Babandingan Dosimetric fokus kana Dampak Manajemén Gerak engapan. |
| Transplantasi Ati Saatos Chemoembolization Transarterial na Radiotherapy pikeun Carcinoma Hepatocellular kalawan Invasi Vascular. |
| Chemoradiotherapy preoperative dituturkeun ku excision lokal dina kanker rectal T2N0 klinis. |
| Prévalénsi jeung significance klinis of mucin sélular jeung acellular di penderita kanker rectal mucinous maju lokal anu underwent chemoradiotherapy preoperative dituturkeun ku bedah radikal. |
| Pangaruh pelindung asam ��-lipoic ngalawan fibrosis anu ngainduksi radiasi dina mencit. |
| Normalisasi alfa-fetoprotein salaku surrogate prognostic dina carcinoma hepatocellular leutik sanggeus radiotherapy awak stereotactic: analisis propensity skor cocog. |
| Éféktivitas radioterapi adjuvant saatos éksisi lokal kanker rectal kalayan invasi submucosal jero: rumah sakit tunggal, analisis kasus-kontrol. |
| Pangaruh Kémoradioterapi Preoperative dina Stratégi Bedah Numutkeun Tahap T Klinis Pasén Kalayan Kanker Réktal. |
